Plus: preventing type 1 diabetes; more
Tuesday, Aug. 24, 2021 : Issue #1161 |
|
Letter from the Editor Today I had 8 Doctor of Pharmacy Candidates on a Teams call to talk about diabetes medications. The goal was to take these students from classroom recitation of information to the real world, where they have to explain things to patients, not professors. As you can guess there was a lot of discussion of side effects, regardless of how minute, and the use of big words like glyconeogenesis, in their explanations. After the first couple of presentations they got the hang of it, and for the most part did a great job explaining the medications without scaring off the patients. One of the other things they had to present was pricing, as we all know that usually influences most drug purchases long term. One of the interns pointed out that Ertugliflozin had a cash price about 40% lower than the other SGLT-2 inhibitors. The consensus was that the drug must not be as good as the others in the class. That was when Andy Dao, PharmD Candidate, University of South Florida Taneja College of Pharmacy, shared an article he had prepared for this week's newsletter that reviewed the Vertis CV trial and proved that this drug was just as effective as the others in class, for patients with type 2 diabetes and ASCVD. ***************************** We can make a difference! ***************************** Dave Joffe Editor-in-chief |
|
| |
|
|
|
TOP STORIES - Diabetes News and Research |
|
| |
|
|
|
| | About LaterPay: You will notice that some of our articles are now marked with a small credit card icon. This means you will be asked to pay a small fee to access the full article text (the cost is $0.39 per article, and you will be charged only after you have reached $5.00 in article views). The costs of producing a newsletter like Diabetes in Control have been increasing, which is why we are asking our readers to help support our ability to continue to bring you quality information about diabetes through charging a minimal price to read certain articles. Thank you for helping to support Diabetes in Control. |
| Your Friends in Diabetes Care Steve and Dave Diabetes In Control www.diabetesincontrol.com |
|
|
|
|
| |
|
|
|
|